Genomic Health (GHDX) Tops Q4 EPS by 2c, FY15 EPS Misses Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) before income taxes: -14.81M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Income (loss) before income taxes: -14.81M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q4 EPS of ($0.20), $0.02 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $69.1 million versus the consensus estimate of $72.2 million.
Genomic Health sees FY2015 EPS of ($0.53)-($0.75), versus the consensus of ($0.52). Genomic Health sees FY2015 revenue of $292-305 million, versus the consensus of $310.61 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deluxe Corp. (DLX) Tops Q3 EPS by 11c; offers guidance
- CoreCivic (CXW) Misses Q3 EPS by 1530c; raises guidance
- Black Hills Corp. (BKH) Tops Q3 EPS by 6c, Misses on Revenue; Offers FY26 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
